Rhythm Pharmaceuticals, Inc. (RYTM)
100.71
-4.47
(-4.25%)
USD |
NASDAQ |
Dec 09, 16:00
101.50
+0.79
(+0.78%)
Pre-Market: 09:25
Rhythm Pharmaceuticals Profit Margin (Quarterly): -103.1% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 39.21% |
| Terns Pharmaceuticals, Inc. | -- |
| Altimmune, Inc. | -380.3K% |
| Viking Therapeutics, Inc. | -- |
| Cidara Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -509.3% |
| Return on Assets | -47.53% |
| Return on Invested Capital | -65.09% |
| Gross Profit Margin (Quarterly) | 89.08% |
| Operating Margin (Quarterly) | -102.6% |
| Return on Net Operating Assets | -363.7% |